🔗 Permalink

Inventor profile of:

Colin Watanabe

City:

Moraga, California

Country:

United States

Published Applications:

Last publication date:

2014-10-30

Top Assignees for applications by Colin Watanabe

The entities that hold a legal rights for patent applications filed by inventor Watanabe Colin:

Genentech, Inc. 10 South San Francisco, CA United States
Genetech, Inc. 1 South San Francisco, CA United States
Genentech, Inc. 1 South San Fracisco, CA United States

Recent patent applications by Watanabe Colin

Colin Watanabe from Moraga, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2014-10-30

US20140323706A1

Chemistry; metallurgy

NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF

#2 | 2013-07-25

US20130189273A1

Human necessities

EG-VEGF NUCLEIC ACIDS AND POLYPEPTIDES AND METHODS OF USE

#3 | 2011-03-17

US20110064728A1

Human necessities

IL-17 Homologous Polypeptides and Therapeutic Uses Thereof

#4 | 2010-10-07

US20100256226A1

Human necessities

EG-VEGF nucleic acids and polypeptides and methods of use

#5 | 2010-10-07

US20100254999A1

Chemistry; metallurgy

EG-VEGF nucleic acids and polypeptides and methods of use

#6 | 2010-02-18

US20100041138A1

Chemistry; metallurgy

Nucleic acids encoding IL-17 homologous receptor-like polypeptides and therapeutic uses thereof

#7 | 2009-12-24

US20090318340A1

Chemistry; metallurgy

IL-17 homologous polypeptides and therapeutic uses thereof

#8 | 2009-11-26

US20090291097A1

Chemistry; metallurgy

IL-17 homologous polypeptides and therapeutic uses thereof

#9 | 2009-10-29

US20090269844A1

Chemistry; metallurgy

Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof

#10 | 2009-09-10

US20090227017A1

Chemistry; metallurgy

NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF

#11 | 2009-09-10

US20090227016A1

Chemistry; metallurgy

Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof

#12 | 2009-05-28

US20090136491A1

Human necessities

IL-17 homologous polypeptides and therapeutic uses thereof

#13 | 2009-05-07

US20090117114A1

Human necessities

IL-17 homologous polypeptides and therapeutic uses thereof

#14 | 2009-04-02

US20090087429A1

Human necessities

IL-17 homologous polypeptides and therapeutic uses thereof

#15 | 2009-02-05

US20090035261A1

Chemistry; metallurgy

IL-17 homologous polypeptides and therapeutic uses thereof

#16 | 2007-09-13

US20070213268A1

Human necessities

EG-VEGF nucleic acids and polypeptides and methods of use

#17 | 2007-09-04

US10027603

EG-VEGF nucleic acids and polypeptides and method of use

#18 | 2007-05-31

US20070122412A1

Chemistry; metallurgy

EG-VEGF nucleic acids and polypeptides and methods of use

#19 | 2006-06-22

US20060134755A1

Chemistry; metallurgy

Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof

#20 | 2006-04-27

US20060088917A1

Chemistry; metallurgy

IL-17 homologous polypeptides and therapeutic uses thereof

#21 | 2006-04-27

US20060088916A1

Chemistry; metallurgy

Receptor for IL-17 homologous polypeptides and uses thereof

#22 | 2005-03-24

US20050064522A1

Chemistry; metallurgy

EG-VEGF nucleic acids and polypeptides and methods of use

InventorID:

353718 ⎘